| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |